Literature DB >> 32845586

One-Year Pharmacovigilance Update of Brodalumab.

Mark Lebwohl, Craig Leonardi, Jashin J Wu, Paul Yamauchi, Nicole Rawnsley, Mohammed Merchant, Binu Alexander, Abby Jacobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32845586     DOI： 10.36849/JDD.2020.5138

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


× No keyword cloud information.
  3 in total

1.  Two-Year US Pharmacovigilance Report on Brodalumab.

Authors:  Mark Lebwohl; Craig Leonardi; Jashin J Wu; April Armstrong; Nicole Rawnsley; Mohammed Merchant; Binu Alexander; Abby Jacobson
Journal:  Dermatol Ther (Heidelb)       Date:  2020-12-18

Review 2.  Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.

Authors:  Akshitha Thatiparthi; Amylee Martin; Jeffrey Liu; Alexander Egeberg; Jashin J Wu
Journal:  Am J Clin Dermatol       Date:  2021-04-16       Impact factor: 7.403

Review 3.  Biologic Treatments of Psoriasis: An Update for the Clinician.

Authors:  Nicholas D Brownstone; Julie Hong; Megan Mosca; Edward Hadeler; Wilson Liao; Tina Bhutani; John Koo
Journal:  Biologics       Date:  2021-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.